StonvexLoading…
StonvexStonvexStonvexCore line items from IPGP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.00B | $977.13M | $1.29B | $1.43B |
Operating Income | $13.10M | $-208.25M | $231.97M | $169.50M |
Net Income | $31.10M | $-181.53M | $218.88M | $109.91M |
EPS (Diluted) | $0.73 | $-4.09 | $4.63 | $2.16 |
Total Assets | $2.42B | $2.29B | $2.70B | $2.74B |
Total Liabilities | $296.15M | $264.79M | $283.51M | $357.92M |
Cash & Equivalents | $403.79M | $620.04M | $514.67M | $698.21M |
Free Cash Flow OCF − CapEx | $-3.45M | $149.37M | $185.50M | $102.51M |
Shares Outstanding | 42.13M | 42.55M | 46.32M | 48.14M |